Wolverine Trading
SIOX

Wolverine Trading’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Wolverine Trading’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-30,300
Closed -$40K – 6827
2021
Q4 		$40K Buy
30,300
+5,400
+22% +$9.58K ﹤0.01% 5393
2021
Q3 		$53K Buy
24,900
+1,300
+6% +$2.83K ﹤0.01% 6010
2021
Q2 		$64K Buy
23,600
+5,600
+31% +$13.9K ﹤0.01% 5553
2021
Q1 		$44K Sell
18,000
-11,600
-39% -$32.8K ﹤0.01% 5676
2020
Q4 		$84K Buy
29,600
+8,200
+38% +$23.9K ﹤0.01% 4511
2020
Q3 		$106K Buy
21,400
+11,100
+108% +$36.6K ﹤0.01% 4114
2020
Q2 		$30K Sell
10,300
-500
-5% -$1.6K ﹤0.01% 4389
2020
Q1 		$25K Sell
10,800
-12,100
-53% -$43.7K ﹤0.01% 4402
2019
Q4 		$115K Sell
22,900
-4,000
-15% -$22.2K ﹤0.01% 4244
2019
Q3 		$178K Buy
+26,900
New +$185K ﹤0.01% 3647
2019
Q1 		– Sell
-3,488
Closed -$28K – 5552
2018
Q4 		$28K Sell
3,488
-50
-1% -$721 ﹤0.01% 4250
2018
Q3 		$68K Sell
3,538
-187
-5% -$3.4K ﹤0.01% 4645
2018
Q2 		$40K Hold
3,725
– – ﹤0.01% 4944
2018
Q1 		$40K Sell
3,725
-7,625
-67% -$122K ﹤0.01% 4944
2017
Q4 		$479K Sell
11,350
-413
-4% -$18.5K ﹤0.01% 3052
2017
Q3 		$647K Buy
+11,763
New +$1.98M ﹤0.01% 2334

Other funds holding SIOX

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
CIA
Cladis Investment Advisory Billings, Montana $182M AUM 33.3% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return

Wolverine Trading's SIOX Position: Q4 2020 in Review

Wolverine Trading sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q4 2020, closing a stake of 12,491 shares — an estimated $36.4K sold.

Wolverine Trading first reported a position in SIOX in Q3 2017 and held it in 2 quarters. The position peaked at $149K in Q3 2017. 62 funds tracked by Wall St. Rank hold SIOX as of Q4 2020.

  • Wolverine Trading reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Wolverine Trading sold 12,491 Sio Gene Therapies Inc. Common Stock shares in Q4 2020, an estimated $36.4K.
  • Wolverine Trading first reported a position in Sio Gene Therapies Inc. Common Stock in Q3 2017 and held it in 2 quarters.
  • Wolverine Trading's Sio Gene Therapies Inc. Common Stock position peaked at $149K in Q3 2017.
  • 62 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q4 2020.

Based on Wolverine Trading's 13F filing for Q4 2020, filed 12 Feb 2021.